← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Seattle Children'S Hospital
Seattle, WA
$1,325,012,371
Total funding
843
Grants
Funding over time
peak $137.2M · FY2005–25$200M$150M$100M$50M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,245,023,296 · 786
CDC$39,033,895 · 17
AHRQ$17,174,107 · 15
DOD$10,671,844 · 8
FDA$7,274,506 · 6
NSF$5,834,723 · 10
SAMHSA$0 · 1
By mechanism
R01$688,836,069 · 303
N01$159,143,368 · 4
U01$85,046,671 · 29
R21$51,285,649 · 115
U19$38,334,064 · 25
U54$36,236,685 · 28
Investigators at Seattle Children'S Hospital
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Largest grants
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)$13,471,730
N01 · FY2019 · AI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)$13,001,420
N01 · FY2021 · AI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)$12,955,056
N01 · FY2023 · AI
Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB)$11,546,233
N01 · FY2024 · AI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)$11,541,977
N01 · FY2020 · AI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)$10,725,373
N01 · FY2023 · AI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)$9,482,062
N01 · FY2024 · AI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)$9,211,989
N01 · FY2022 · AI
Behavior of HIV in Viral Environments (B-HIVE)$6,759,300
U54 · FY2023 · AI
Behavior of HIV in Viral Environments (B-HIVE)$6,289,044
U54 · FY2022 · AI
Behavior of HIV in Viral Environments (B-HIVE)$5,911,895
U54 · FY2024 · AI
Behavior of HIV in Viral Environments (B-HIVE)$5,862,824
U54 · FY2025 · AI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)$5,781,274
N01 · FY2022 · AI
Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB)$5,443,065
N01 · FY2024 · AI
HIV Interactions In Viral Evolution$5,340,254
U54 · FY2021 · AI
HIV Interactions In Viral Evolution$5,014,695
U54 · FY2020 · AI
Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB)$4,901,576
N01 · FY2025 · AI
Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB)$4,805,147
N01 · FY2025 · AI
An integrated strategy to define the functional and synergistic impact of T1D causal variants$4,411,432
DP3 · FY2016 · DK
Effectiveness of an mHealth psychosocial intervention to prevent transition from acute to chronic postsurgical pain in adolescents$4,182,503
UH3 · FY2020 · HD